Using SERS, researchers from Iowa State University, University of Nebraska Medical Center, University of Pittsburgh Medical Center, and University of Utah demonstrate the first ever detection of the potential pancreatic cancer marker MUC4 in cancer patient serum samples [113]. This evidence concerns the gene MUC4 and pancreatic neoplasm.